News
Press Releases
Pr
Press Release
Seqens confirms the acquisition of CELLforCURE
SEQENS confirms the acquisition of the CELLforCURE site at Les Ulis (91) from NOVARTIS as of December 1st, 2023.
Events and more
01
February 25-27 / London, UK
//Meet us booth #9//
This is an essential forum to stay at the forefront of the latest innovations in cell therapy. Join us to collaborate, innovate, and overcome common challenges such as security issues, products high cost, effective tumor targeting, and more…
02
March 18-19 / London, UK
//Meet us booth #72//
Follow our presentation « Why, When, and How to Partner with a CDMO: Understanding the Key Milestones»
March 18 at 3.50 PM
Track 10: Cell therapy manufacturing
03
March 19 – 20 / Tours, FR
//Meet us booth #29//
France bioproduction brings together the key players and decision-makers in pharmaceutical bioproduction from France and Europe for an event focused on innovation, collaboration, and exchange.
04
May 13-17, / New Orleans, LA
//Meet us booth #1047//
The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.
05
November 11-12 / London, UK
//Meet us booth #44//
Follow our presentation, November 12 at 11.15 AM
Track 2: Strategies for Cell Therapy Manufacturing
